Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
Titel:
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
Auteur:
Haag, G.M. Zoernig, I. Hassel, J.C. Halama, N. Dick, J. Lang, N. Podola, L. Funk, J. Ziegelmeier, C. Juenger, S. Bucur, M. Umansky, L. Falk, C.S. Freitag, A. Karapanagiotou-Schenkel, I. Beckhove, P. Enk, A. Jaeger, D.